Screening the Tox21 Compound Library for Chemicals That Stimulate the Adrenergic β1 Receptor
Chemical Research in Toxicology · 17.08.2026 · 39 (8) · 1508-1517
DOI: 10.1021/acs.chemrestox.5c00501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 14.07.2026. Verfasst von Precious A Adesina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland20892, Uni…. Hauptthemen laut MEDLINE: Receptors, Adrenergic, beta-1, Small Molecule Libraries, Adrenergic beta-1 Receptor Agonists. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
Beta-1 adrenergic receptors (ADRβ1) are critical regulators of cardiac function; however, the potential modulation of ADRβ1 by environmental chemicals remains largely underexplored, raising concerns about unintended impacts on cardiovascular health. We applied a quantitative high-throughput screening (qHTS) approach to identify ADRβ1 agonists within the Tox21 10K compound library, which includes environmental chemicals, pharmaceuticals, industrial agents, and consumer products, using an HTRF-based cAMP assay in ADRβ1-overexpressing HEK293 cells. Primary screening of 8,947 unique compounds identified 118 potential ADRβ1 agonists. Among these, 94 were confirmed and further evaluated for β-adrenergic receptor subtype selectivity (ADRβ2 and ADRβ3) and hERG channel inhibition to assess potential cardiotoxicity liability. Known ADRβ1 agonists, isoproterenol (EC50, 0.91 nM) and dobutamine (EC50, 10 nM), were identified, supporting the validity of the assay. In addition, several compounds with limited prior ADRβ1-specific characterization, such as GR 103691 and N,N′-dibenzylethane-1,2-diamine, demonstrated subtype-selective or mixed agonist profiles, with some exhibiting minimal hERG inhibition. These findings expand the catalog of ADRβ1 modulators and demonstrate the utility of qHTS for identifying chemicals that may affect cardiovascular signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland20892, United States.
- Division of Translational Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina27709, United States.
ORCID-Profile: Srilatha Sakamuru, Stephen S Ferguson, Jui-Hua Hsieh, Ruili Huang, Menghang Xia
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
Zitieren
APA
Adesina, P. A., Zhang, L., Sukhawanit, C., Wood, S., Zhao, J., Li, Z., Sakamuru, S., Ferguson, S. S., Hsieh, J. H., Reif, D. M., Huang, R., & Xia, M. (2026). Screening the Tox21 Compound Library for Chemicals That Stimulate the Adrenergic β1 Receptor. Chemical Research in Toxicology, 39(8), 1508-1517. https://doi.org/10.1021/acs.chemrestox.5c00501
Vancouver
Adesina PA, Zhang L, Sukhawanit C, Wood S, Zhao J, Li Z, et al. Screening the Tox21 Compound Library for Chemicals That Stimulate the Adrenergic β1 Receptor. Chemical Research in Toxicology. 2026;39(8):1508-1517. doi:10.1021/acs.chemrestox.5c00501
BibTeX
@article{Adesina2026,
author = {Adesina, Precious A and Zhang, Li and Sukhawanit, Chainarong and Wood, Savannah and Zhao, Jinghua and Li, Zoe and Sakamuru, Srilatha and Ferguson, Stephen S and Hsieh, Jui-Hua and Reif, David M and Huang, Ruili and Xia, Menghang},
title = {Screening the Tox21 Compound Library for Chemicals That Stimulate the Adrenergic β1 Receptor},
journal = {Chemical Research in Toxicology},
year = {2026},
volume = {39},
number = {8},
pages = {1508--1517},
doi = {10.1021/acs.chemrestox.5c00501}
}
EUVIMED